BNTC Benitec Corp: Bozor kapitallashuvining balans qiymatiga nisbati
Benitec Biopharma Inc. (BNTC) uchun ushbu narxlar grafigi patogen oqsillarni bitta inyeksiya orqali bloklashdagi innovatsiyalar tufayli yuzaga kelgan tebranishlarni namoyish etadi. Biroq, operatsion richagning yetishmasligi va yuqori tadqiqot xarajatlari ko'rsatkichni 1.69 darajasida ushlab turibdi. Biznes noyob patologiyalarni davolashda RNK interferentsiyasiga tayanadi va global genetik muhandislik bozorida o'z kuchlarini okulofaringeal mushak distrofiyasini davolashga qaratadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_BNTC_-_Benitec-Biopharma-Inc._-_Capitalization-to-Book-Value-Ratio "benitec.com (BNTC) - Bozor qiymatining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha | 👁️GURU.Markets👁️")
BNTC (Benitec Biopharma Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Fundamental baholash:BNTC, Benitec Biopharma Inc.
Emitentning uzoq muddatli ishonchliligi bozorning uning aktivlarini nominal qiymatdan yuqori baholash qobiliyati bilan belgilanadi, bu esa kelajakdagi o'sish uchun premium ko'rsatkichi sifatida bozor kapitalizatsiyasining balans qiymatiga nisbatini aks ettiradi. Benitec Biopharma Inc. (BNTC) uchun ushbu ko'rsatkich investorlarning spekulyativ kutganlarini o'lchaydi, chunki tijorat sotuvlarining yo'qligi va FDA tasdig'iga bog'liqlik joriy kapitalni shunchaki kelajakdagi ishlanmalar uchun asosga aylantiradi.
Raqobatchilar tahlili
TEM (Tempus Labs) - Bozor kapitallashuvining balans qiymatiga nisbati|qiagen.com (QGEN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor kapitallashuvining balans qiymatiga nisbati|SRPT - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TWST|TXG (10x) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics (NTLA)|Kapitallashuvning balans qiymatiga nisbati stoketherapeutics.com|BLFS (BioLife Solutions) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Wave Life Sciences Ltd WVE|Kapitallashuvning sof aktivlarga nisbati Maze Tx (MAZE)|Bozor kapitallashuvining balans qiymatiga multiplikatori Sionna Corp SION|PRME (Prime Medicine, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|TSHA - Bozor qiymatining balans qiymatiga koeffitsiyenti|QURE (uniQure) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati MeiraGTx Holdings|RGNX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp|Bozor kapitallashuvining balans qiymatiga nisbati Ocugen, Inc. (OCGN)|Bozor qiymatining balans qiymatiga nisbati pacb.com (PACB)|Bozor kapitallashuvining balans qiymatiga nisbati DSGN|Rocket Pharma - Balans qiymatiga nisbatan bozor kapitallashuvi|FDMT (4D Molecular Therapeutics Inc) - Bozor qiymatining balans qiymatiga nisbati|LXEO: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati korrobio.com (KRRO)|editasmedicine.com (EDIT) - Sof aktivlarga nisbatan bozor kapitallashuvi|SLN - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ProQR Therapeutics NV|Bozor kapitallashuvining balans qiymatiga nisbati CDXS|Bozor kapitallashuvining balans qiymatiga nisbati SGMO (Sangamo BioSciences)|Bozor qiymatining balans qiymatiga nisbati Nautilus Bio|metagenomi.co - Balans qiymatiga nisbatan bozor qiymati|DTIL: Bozor qiymatining balans qiymatiga nisbati|GBIO - Kapitallashuvning sof aktivlarga nisbati|BOLD: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Exicure|IMNN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RXi Pharmaceuticals|MBIO (Mustang Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|BLUE: Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|Singular Genomics Systems, Inc. (OMIC) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc|Bozor qiymatining balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com TCON|Kapitallashuvning sof aktivlarga nisbati Unity Biotechnology, Inc. (UBX)